Form 8-K - Current report:
SEC Accession No. 0001157523-07-001215
Filing Date
2007-02-07
Accepted
2007-02-07 16:11:11
Documents
2
Period of Report
2007-02-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC., 8-K a5328809.txt 8-K 4114
2 EXHIBIT 99.1 a5328809-ex991.txt EX-99.1 29330
  Complete submission text file 0001157523-07-001215.txt   35043
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50743 | Film No.: 07588270
SIC: 2834 Pharmaceutical Preparations